News Releases
August 8, 2019
Synlogic Reports Second Quarter 2019 Financial Results and Provides Program Updates
August 1, 2019
Synlogic Announces Second Quarter 2019 Conference Call and Webcast
July 15, 2019
Synlogic Reports Positive Top-line Data from Phase 1/2a Study of SYNB1618 in Patients with Phenylketonuria and Guides to Next Phase of Development
June 12, 2019
Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines
May 22, 2019
Synlogic Announces Clinical Collaboration to Evaluate SYNB1891 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors
May 9, 2019
Synlogic Reports First Quarter 2019 Financial Results and Provides Business Update
May 2, 2019
Synlogic Announces First Quarter 2019 Conference Call and Webcast
April 30, 2019
Synlogic Presents Data Describing a Solid Oral Formulation Process for Synthetic Biotic™ Medicine SYNB1618 for the Treatment of PKU at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
April 15, 2019
Synlogic to Present Data from New Solid Oral Formulation Process at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
April 9, 2019
Synlogic Appoints Scott Plevy M.D. as Chief Scientific Officer
April 2, 2019
Synlogic to Webcast Presentation at the 18th Annual Needham Healthcare Conference
Displaying 37 - 48 of 124